Clinical Decision Support Systems in Hospitalized Older Patients: An Exploratory Analysis in a Real-Life Clinical Setting

被引:2
|
作者
Linkens, Aimee E. M. J. H. [1 ,2 ]
Kurstjens, Dennis [3 ]
Zwietering, N. Anne [2 ,4 ]
Milosevic, Vanja [5 ]
Hurkens, Kim P. G. M. [3 ]
van Nie, Noemi [6 ]
van de Loo, Bob P. A. [7 ]
van der Kuy, P. Hugo M. [2 ]
Spaetgens, Bart [1 ,8 ]
机构
[1] Maastricht Univ, Dept Internal Med, Div Gen Internal Med, Sect Geriatr Med,Med Ctr, POB 5800, NL-6202 AZ Maastricht, Netherlands
[2] Erasmus MC, Univ Med Ctr Rotterdam, Dept Hosp Pharm, NL-3015 GD Rotterdam, Netherlands
[3] Zuyderland Med Ctr, Dept Internal Med, Geriatr Med, Heerlen, Netherlands
[4] Laurentius Hosp, Dept Geriatr Med, Roermond, Netherlands
[5] Elkerliek Hosp, Clin Pharm, Helmond, Netherlands
[6] Zuyderland Med Ctr, Dept Res Innovat & Funding, Heerlen, Limburg, Netherlands
[7] Digitalis Rx BV, Amsterdam, Netherlands
[8] Maastricht Univ, Dept Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
关键词
STRUCTURED PHARMACIST INTERVENTION; MEDICATION USE;
D O I
10.1007/s40801-023-00365-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundInappropriate prescribing is associated with negative patient outcomes. In hospitalized patients, the use of Clinical Decision Support Systems (CDSSs) may reduce inappropriate prescribing and thereby improve patient-related outcomes. However, recently published large clinical trials (OPERAM and SENATOR) have shown negative results on the use of CDSSs and patient outcomes and strikingly low acceptance of recommendations.ObjectiveThe purpose of the present study was to investigate the use of a CDSS in a real-life clinical setting of hospitalized older patients. As such, we report on the real-life pattern of this in-hospital implemented CDSS, including (i) whether generated alerts were resolved; (ii) whether a recorded action by the pharmacist led to an improved number of resolved alerts; and (iii) the natural course of generated alerts, in particular of those in the non-intervention group; as these data are largely lacking in current studies.MethodsHospitalized patients, aged 60 years and older, admitted to Zuyderland Medical Centre, the Netherlands, in 2018 were included. The evaluation of the CDSS was investigated using a database used for standard care. Alongside demographic and clinical data, we also collected the total numbers of CDSS alerts, the number of alerts 'handled' by the pharmacist, those that resulted in an action by the pharmacist, and finally the outcome of the alerts at day 1 and day 3 after the alert was generated.ResultsA total of 3574 unique hospitalized patients, mean age 76.7 (SD 8.3) years and 53% female, were included. From these patients, 8073 alerts were generated, of which 7907 (97.9% of total) were handled by the pharmacist (day 1). In 51.6% of the alerts handled by the pharmacist, an action was initiated, resulting in 36.1% of the alerts resolved after day 1, compared with 27.3% if the pharmacist did not perform an action (p < 0.001). On day 3, in 52.6% of the alerts an action by the pharmacist was initiated, resulting in 62.4% resolved alerts, compared with 48.0% when no action was performed (p < 0.001). In the category renal function, the percentages differed significantly between an action versus no action of the pharmacist at day 1 and at day 3 (16.6% vs 10.6%, p < 0.001 [day 1]; 29.8% vs 19.4%, p < 0.001 [day 3]).ConclusionThis study demonstrates the pattern and natural course of clinical alerts of an in-hospital implemented CDSS in a real-life clinical setting of hospitalized older patients. Besides the already known beneficial effect of actions by pharmacists, we have also shown that many alerts become resolved without any specific intervention. As such, our study provides an important insight into the spontaneous course of resolved alerts, since these data are currently lacking in the literature.
引用
收藏
页码:363 / 370
页数:8
相关论文
共 50 条
  • [21] Does a clinical study reflect real-life and real-life costs
    Juhl, HH
    Hvenegaard, A
    Schmidt, VM
    Habicht, A
    VALUE IN HEALTH, 2005, 8 (03) : 373 - 374
  • [22] Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis
    Halpern, Naama
    Goldberg, Yael
    Kadouri, Luna
    Duvdevani, Morasha
    Hamburger, Tamar
    Peretz, Tamar
    Hubert, Ayala
    ONCOTARGETS AND THERAPY, 2017, 10 : 1889 - 1896
  • [23] Oscillometry to support clinical assessment in asthmatic preschoolers: Real-life impact
    Desormeau, Bennet
    Smyrnova, Anna
    Drouin, Olivier
    Ducharme, Francine Monique
    RESPIRATORY MEDICINE, 2023, 209
  • [24] Clinical outcomes of diabetic patients in a real life setting
    Wiemer, M.
    Barbato, E.
    Perisic, Z.
    Apro, D.
    Korpilahti, K.
    Benedetto, M.
    Lotan, C.
    Marzocchi, A.
    Danzi, G. B.
    West, N.
    EUROPEAN HEART JOURNAL, 2010, 31 : 668 - 668
  • [25] Clinical outcome of primary CNS lymphoma comparing the setting of "real-life" with a clinical trial: A single centre experience of 95 patients
    Zeremski, V
    Fischer, T.
    Schalk, E.
    Oncology Research and Treatment, 2015, 38 : 211 - 212
  • [26] Children and Adults with PFAPA Syndrome: Similarities and Divergences in a Real-Life Clinical Setting
    Sicignano, Ludovico Luca
    Rigante, Donato
    Moccaldi, Beatrice
    Massaro, Maria Grazia
    Delli Noci, Stefano
    Patisso, Isabella
    Capozio, Giovanna
    Verrecchia, Elena
    Manna, Raffaele
    ADVANCES IN THERAPY, 2021, 38 (02) : 1078 - 1093
  • [27] CLINICAL AND ECONOMIC BURDEN OF TYPE 1 DIABETES IN REAL-LIFE SETTING IN SPAIN
    Sicras-Mainar, A.
    Navarro-Artieda, R.
    VALUE IN HEALTH, 2018, 21 : S125 - S126
  • [28] Children and Adults with PFAPA Syndrome: Similarities and Divergences in a Real-Life Clinical Setting
    Ludovico Luca Sicignano
    Donato Rigante
    Beatrice Moccaldi
    Maria Grazia Massaro
    Stefano Delli Noci
    Isabella Patisso
    Giovanna Capozio
    Elena Verrecchia
    Raffaele Manna
    Advances in Therapy, 2021, 38 : 1078 - 1093
  • [29] CLINICAL AND ECONOMIC CONSEQUENCES OF TYPE 1 DIABETES IN REAL-LIFE SETTING IN SPAIN
    Sicras, A.
    Ayma, J.
    Marti, B.
    Navarro, R.
    Delbaere, A.
    Deben, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A83 - A84
  • [30] Real-life clinical experience with Eviplera™
    Gothard, A.
    Wilkins, E.
    Ustianowski, A.
    HIV MEDICINE, 2013, 14 : 58 - 58